{"id":361355,"date":"2025-08-30T17:05:42","date_gmt":"2025-08-30T17:05:42","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-dianthus-therapeutics\/"},"modified":"2025-08-30T17:05:42","modified_gmt":"2025-08-30T17:05:42","slug":"how-to-buy-dianthus-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/","title":{"rendered":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334081,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-361355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131"},"description":"Dianthus Therapeutics (DNTH) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Dianthus Therapeutics (DNTH) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile \u00f6\u011frenin."},"intro":"\u0130leri biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Dianthus Therapeutics, b\u00fcy\u00fck potansiyelin \u00f6nemli risklerle bulu\u015ftu\u011fu klinik a\u015famadaki biyoteknoloji d\u00fcnyas\u0131n\u0131n heyecan verici temsilcisidir. Bu \u015firket, otoimm\u00fcn hastal\u0131klar i\u00e7in devrim niteli\u011finde tedaviler geli\u015ftiriyor ve hisseleri t\u0131bbi yeniliklere kat\u0131lman\u0131z i\u00e7in biletiniz olabilir. G\u00fcncel fiyatland\u0131rmadan ilk yat\u0131r\u0131m\u0131n\u0131z\u0131 yapman\u0131n pratik ad\u0131mlar\u0131na kadar her \u015feyi a\u00e7\u0131klayaca\u011f\u0131z.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri biyoteknolojiye yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Dianthus Therapeutics, b\u00fcy\u00fck potansiyelin \u00f6nemli risklerle bulu\u015ftu\u011fu klinik a\u015famadaki biyoteknoloji d\u00fcnyas\u0131n\u0131n heyecan verici temsilcisidir. Bu \u015firket, otoimm\u00fcn hastal\u0131klar i\u00e7in devrim niteli\u011finde tedaviler geli\u015ftiriyor ve hisseleri t\u0131bbi yeniliklere kat\u0131lman\u0131z i\u00e7in biletiniz olabilir. G\u00fcncel fiyatland\u0131rmadan ilk yat\u0131r\u0131m\u0131n\u0131z\u0131 yapman\u0131n pratik ad\u0131mlar\u0131na kadar her \u015feyi a\u00e7\u0131klayaca\u011f\u0131z."},"body_html":"<h2>\ud83d\udcc8 Dianthus Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>30 A\u011fustos 2025 itibar\u0131yla Dianthus Therapeutics (DNTH), NASDAQ'ta <strong>23,57 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>Eyl\u00fcl 2025 kesinlikle kritik<\/strong> - \u015firket, \u00f6nc\u00fc ila\u00e7 aday\u0131 DNTH103 i\u00e7in Faz 2 MaGic deneme sonu\u00e7lar\u0131n\u0131 bu tarihte a\u00e7\u0131klayacak.<\/p> <h3>Neden Eyl\u00fcl Bu Kadar \u00d6nemli<\/h3> <p>Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131na ba\u011fl\u0131 olarak y\u00fckselir veya d\u00fc\u015fer. Yakla\u015fan Eyl\u00fcl veri a\u00e7\u0131klamas\u0131 DNTH'nin y\u00fckselmesine veya \u00e7\u00f6kmesine neden olabilir. Tarihsel olarak, benzer biyoteknoloji \u015firketleri b\u00fcy\u00fck deneme sonu\u00e7lar\u0131n\u0131n ard\u0131ndan g\u00fcnler i\u00e7inde <strong>%50-100 aras\u0131 hareketler<\/strong> ya\u015fad\u0131.<\/p> <p>2025'ten g\u00fcncel \u00f6rnekler:<\/p> <ul> <li><strong>Neurocrine Biosciences<\/strong>, \u015eubat ay\u0131nda olumlu Faz 3 sonu\u00e7lar\u0131n\u0131n ard\u0131ndan %42 y\u00fckseldi<\/li> <li><strong>Sage Therapeutics<\/strong>, Nisan ay\u0131nda ba\u015far\u0131s\u0131z depresyon denemesinin ard\u0131ndan %62 d\u00fc\u015ft\u00fc<\/li> <li><strong>BridgeBio Pharma<\/strong>, Haziran ay\u0131nda olumlu genetik bozukluk verileriyle %78 artt\u0131<\/li> <\/ul> <p>Desen a\u00e7\u0131k: ikili olaylar b\u00fcy\u00fck volatilite yarat\u0131r. DNTH i\u00e7in Eyl\u00fcl tam olarak b\u00f6yle bir yap ya da y\u0131k an\u0131d\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: D\u00f6nme Dolap S\u00fcr\u00fc\u015f\u00fc<\/h2> <p>Dianthus hisseleri Mart 2025'ten beri olduk\u00e7a hareketli bir yolculuk yapt\u0131:<\/p> <p><strong>Mart 2025<\/strong>: 18-20 $ aral\u0131\u011f\u0131 (deneme kayd\u0131 \u00f6ncesi sessiz d\u00f6nem)<br\/> <strong>May\u0131s 2025<\/strong>: 25 $+ seviyelerine s\u0131\u00e7rama (65 hastayla Faz 2 kayd\u0131n\u0131n ba\u015far\u0131l\u0131 tamamlanmas\u0131)<br\/> <strong>Temmuz 2025<\/strong>: 19-21 $ aral\u0131\u011f\u0131na d\u00fczeltme (genel biyoteknoloji sekt\u00f6r\u00fc zay\u0131fl\u0131\u011f\u0131)<br\/> <strong>A\u011fustos 2025<\/strong>: 23-24 $ seviyelerine toparlanma (Eyl\u00fcl sonu\u00e7lar\u0131 i\u00e7in beklenti art\u0131\u015f\u0131)<\/p> <p>Hisse, g\u00fcnl\u00fck %6-8 dalgalanmalarla <strong>a\u015f\u0131r\u0131 volatilite<\/strong> g\u00f6sterdi. Bu, cesaret isteyen bir durum - bir g\u00fcn i\u00e7inde bir\u00e7ok mavi \u00e7ip hissenin y\u0131ll\u0131k hareketinden daha fazla hareket edebilen bir hisseyle kar\u015f\u0131 kar\u015f\u0131yay\u0131z.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 (Eyl\u00fcl Sonras\u0131)<\/strong>: \u0130ki olas\u0131 senaryo:<\/p> <ul> <li><em>Olumlu Sonu\u00e7lar<\/em>: 40-60 $ aral\u0131\u011f\u0131 (%70-150 y\u00fckseli\u015f)<\/li> <li><em>Olumsuz Sonu\u00e7lar<\/em>: 12-18 $ aral\u0131\u011f\u0131 (%20-50 d\u00fc\u015f\u00fc\u015f)<\/li> <\/ul> <p><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Eyl\u00fcl sonu\u00e7lar\u0131 olumluysa, Faz 3 planlamas\u0131 h\u0131zlanarak 65-85 $ beklenir. Olumsuzsa, di\u011fer \u00fcr\u00fcn hatt\u0131 varl\u0131klar\u0131 etraf\u0131nda yeniden yap\u0131land\u0131rma 15-25 $ aral\u0131\u011f\u0131n\u0131 destekleyebilir.<\/p> <p><strong>2028 Projeksiyonu<\/strong>: Ba\u015far\u0131l\u0131 ticarile\u015fme DNTH'yi 120-180 $ seviyelerine ta\u015f\u0131yabilir, bu da n\u00f6rom\u00fcsk\u00fcler hastal\u0131k alan\u0131nda milyar dolarl\u0131k piyasa de\u011feri anlam\u0131na gelir.<\/p> <p><strong>2030 Vizyonu<\/strong>: Kompleman terap\u00f6tiklerinde pazar liderli\u011fi, kusursuz klinik program y\u00fcr\u00fctmesiyle 250 $+ de\u011ferlemeleri hakl\u0131 \u00e7\u0131karabilir.<\/p> <p><strong>Karar<\/strong>: <strong>Y\u00dcKSEK R\u0130SKL\u0130 ALIM<\/strong> - sadece spek\u00fclatif portf\u00f6y k\u0131sm\u0131 i\u00e7in uygundur. Eyl\u00fcl kataliz\u00f6r\u00fc bu yat\u0131r\u0131m\u0131 ikili bir bahise d\u00f6n\u00fc\u015ft\u00fcr\u00fcr - ya b\u00fcy\u00fck kazan\u00e7lar ya da ac\u0131 kay\u0131plar.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Gece Uykunuzu Ka\u00e7\u0131racak Riskler<\/h3> <ul> <li><strong>Klinik Ba\u015far\u0131s\u0131zl\u0131k Riski<\/strong>: \u0130la\u00e7lar\u0131n %90'\u0131 klinik denemelerde ba\u015far\u0131s\u0131z olur. DNTH103 de bunlara kat\u0131labilir.<\/li> <li><strong>Nakit T\u00fcketimi<\/strong>: 309 milyon $ nakit olmas\u0131na ra\u011fmen, \u00e7eyrek ba\u015f\u0131na 30+ milyon $ kaybediyorlar (<a href=\"https:\/\/stockanalysis.com\/stocks\/dnth\/company\/\">2025 2. \u00c7eyrek Sonu\u00e7lar\u0131<\/a>)<\/li> <li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri benzer kompleman inhibit\u00f6rleri geli\u015ftiriyor<\/li> <li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onay\u0131 iyi verilse bile asla garanti de\u011fildir<\/li> <\/ul> <h3>Yat\u0131r\u0131mc\u0131lara Umut Veren Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Oybirli\u011fi Analist Deste\u011fi<\/strong>: T\u00fcm 12 analist AL \u00f6nerisi veriyor, ortalama hedef fiyat 52 $ (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/DNTH\/forecast\/\">MarketBeat Verileri<\/a>)<\/li> <li><strong>Pazar F\u0131rsat\u0131<\/strong>: Sadece ABD'de 100.000+ gMG hastas\u0131 daha iyi tedaviye ihtiya\u00e7 duyuyor<\/li> <li><strong>Mali Dayanak<\/strong>: Nakit 2027 sonuna kadar geli\u015ftirme i\u00e7in zaman sa\u011fl\u0131yor<\/li> <li><strong>Son Kurumsal Al\u0131mlar<\/strong>: <a href=\"https:\/\/dianthustx.com\">Candriam S.C.A.<\/a> ve di\u011fer fonlar pozisyon art\u0131r\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Ak\u0131ll\u0131ca Tahsis Edin<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 tek bir biyotek hisseye koymay\u0131n<\/li> <li><strong>A\u00e7\u0131kl\u0131k Bekleyin<\/strong>: \u0130kili riski \u00f6nlemek i\u00e7in Eyl\u00fcl sonu\u00e7lar\u0131n\u0131 BEKLEMEY\u0130 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Sonu\u00e7lar \u00f6ncesi al\u0131m yapacaksan\u0131z, al\u0131mlar\u0131 birka\u00e7 haftaya yay\u0131n\u0131z<\/li> <li><strong>Stop-Loss Koyun<\/strong>: Volatilite nedeniyle %15-20 stop-loss ile kendinizi koruyun<\/li> <\/ol> <p>Espiri: \"DNTH ticareti, t\u0131bbi e\u011fitim olmadan beyin cerrahisi yapmak gibidir - heyecan verici ama hastay\u0131... ve g\u00f6mle\u011finizi kaybedebilece\u011finizi fark edene kadar!\"<\/p> <h2>\u2705 Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ hisselerini sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesap A\u00e7\u0131n ve Fon Yat\u0131r\u0131n<\/td><td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>DNTH'yi \u0130yice Ara\u015ft\u0131r\u0131n<\/td><td>Kompleman inhibit\u00f6rl\u00fc\u011f\u00fc yakla\u015f\u0131m\u0131n\u0131n bilimini anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Limit Emri Verin<\/td><td>Volatil piyasalarda fazla \u00f6deme yapmamak i\u00e7in maksimum fiyat\u0131 yakla\u015f\u0131k 24 $ olarak belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Klinik Takvimi Takip Edin<\/td><td>Eyl\u00fcl sonu\u00e7 tarihini izleyin ve volatiliteye haz\u0131rlan\u0131n<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Biyotek Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun<\/h2> <p><a href=\"\/blog\">Pocket Option blog<\/a> stratejileriyle ilgilenenler i\u00e7in platform, biyotek ticareti i\u00e7in benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - K\u00fc\u00e7\u00fck pozisyonlarla denemek i\u00e7in m\u00fckemmel<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> - Tek belge KYC ile dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li> <li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong> - Karlar\u0131n\u0131za \u00e7e\u015fitli y\u00f6ntemlerle eri\u015fin<\/li> <li><strong>Ger\u00e7ek zamanl\u0131 uyar\u0131lar<\/strong> - Fiyat hareketleri ve haber olaylar\u0131ndan an\u0131nda haberdar olun<\/li> <\/ul> <p>D\u00fc\u015f\u00fck giri\u015f engeli, Pocket Option'u DNTH gibi y\u00fcksek volatiliteye sahip hisselerle denemek isteyen yeni ba\u015flayanlar i\u00e7in ideal k\u0131lar, b\u00fcy\u00fck sermaye taahh\u00fct etmeden.<\/p> <h2>\ud83c\udf0d Dianthus 2025'te: Otoimm\u00fcn Tedavide Devrim<\/h2> <p>Dianthus Therapeutics, otoimm\u00fcn hastal\u0131klara y\u00f6nelik \u00f6zel bir imm\u00fcnoloji alan\u0131 olan kompleman terap\u00f6tiklerinde \u00f6nc\u00fc konumdad\u0131r. \u00d6nc\u00fc ila\u00e7lar\u0131 claseprubart (DNTH103), miyastenia gravis gibi durumlar\u0131 tedavi etmek i\u00e7in klasik kompleman yolunu se\u00e7ici olarak inhibe eden yenilik\u00e7i bir yakla\u015f\u0131md\u0131r.<\/p> <p>\u015eirket, Faz 2 kayd\u0131n\u0131 planlanandan \u00f6nce tamamlad\u0131 ve 300 milyon dolar\u0131n \u00fczerinde nakit ile g\u00fc\u00e7l\u00fc finansal destek sa\u011fl\u0131yor. Onlar\u0131 \u00f6zellikle ilgin\u00e7 k\u0131lan, herkese her \u015feyi yapmaya \u00e7al\u0131\u015fmak yerine, en iyi s\u0131n\u0131f stat\u00fcs\u00fcne ula\u015fabileceklerine inand\u0131klar\u0131 kompleman inhibit\u00f6rl\u00fc\u011f\u00fcne odaklanmalar\u0131d\u0131r.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025'te Dianthus ara\u015ft\u0131rmac\u0131lar\u0131, ila\u00e7 adaylar\u0131n\u0131n 60 g\u00fcnl\u00fck yar\u0131 \u00f6mr\u00fcn\u00fcn (antikorlar i\u00e7in ola\u011fan\u00fcst\u00fc uzun) haftal\u0131k enjeksiyonlar yerine ayl\u0131k dozlamaya izin verebilece\u011fini ke\u015ffettiler - klinik denemeler ba\u015far\u0131l\u0131 olursa hasta ya\u015fam kalitesi i\u00e7in potansiyel bir oyun de\u011fi\u015ftirici.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Dianthus Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>30 A\u011fustos 2025 itibar\u0131yla Dianthus Therapeutics (DNTH), NASDAQ&#8217;ta <strong>23,57 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>Eyl\u00fcl 2025 kesinlikle kritik<\/strong> &#8211; \u015firket, \u00f6nc\u00fc ila\u00e7 aday\u0131 DNTH103 i\u00e7in Faz 2 MaGic deneme sonu\u00e7lar\u0131n\u0131 bu tarihte a\u00e7\u0131klayacak.<\/p>\n<h3>Neden Eyl\u00fcl Bu Kadar \u00d6nemli<\/h3>\n<p>Biyoteknoloji hisseleri klinik deneme sonu\u00e7lar\u0131na ba\u011fl\u0131 olarak y\u00fckselir veya d\u00fc\u015fer. Yakla\u015fan Eyl\u00fcl veri a\u00e7\u0131klamas\u0131 DNTH&#8217;nin y\u00fckselmesine veya \u00e7\u00f6kmesine neden olabilir. Tarihsel olarak, benzer biyoteknoloji \u015firketleri b\u00fcy\u00fck deneme sonu\u00e7lar\u0131n\u0131n ard\u0131ndan g\u00fcnler i\u00e7inde <strong>%50-100 aras\u0131 hareketler<\/strong> ya\u015fad\u0131.<\/p>\n<p>2025&#8217;ten g\u00fcncel \u00f6rnekler:<\/p>\n<ul>\n<li><strong>Neurocrine Biosciences<\/strong>, \u015eubat ay\u0131nda olumlu Faz 3 sonu\u00e7lar\u0131n\u0131n ard\u0131ndan %42 y\u00fckseldi<\/li>\n<li><strong>Sage Therapeutics<\/strong>, Nisan ay\u0131nda ba\u015far\u0131s\u0131z depresyon denemesinin ard\u0131ndan %62 d\u00fc\u015ft\u00fc<\/li>\n<li><strong>BridgeBio Pharma<\/strong>, Haziran ay\u0131nda olumlu genetik bozukluk verileriyle %78 artt\u0131<\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k: ikili olaylar b\u00fcy\u00fck volatilite yarat\u0131r. DNTH i\u00e7in Eyl\u00fcl tam olarak b\u00f6yle bir yap ya da y\u0131k an\u0131d\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: D\u00f6nme Dolap S\u00fcr\u00fc\u015f\u00fc<\/h2>\n<p>Dianthus hisseleri Mart 2025&#8217;ten beri olduk\u00e7a hareketli bir yolculuk yapt\u0131:<\/p>\n<p><strong>Mart 2025<\/strong>: 18-20 $ aral\u0131\u011f\u0131 (deneme kayd\u0131 \u00f6ncesi sessiz d\u00f6nem)<br \/> <strong>May\u0131s 2025<\/strong>: 25 $+ seviyelerine s\u0131\u00e7rama (65 hastayla Faz 2 kayd\u0131n\u0131n ba\u015far\u0131l\u0131 tamamlanmas\u0131)<br \/> <strong>Temmuz 2025<\/strong>: 19-21 $ aral\u0131\u011f\u0131na d\u00fczeltme (genel biyoteknoloji sekt\u00f6r\u00fc zay\u0131fl\u0131\u011f\u0131)<br \/> <strong>A\u011fustos 2025<\/strong>: 23-24 $ seviyelerine toparlanma (Eyl\u00fcl sonu\u00e7lar\u0131 i\u00e7in beklenti art\u0131\u015f\u0131)<\/p>\n<p>Hisse, g\u00fcnl\u00fck %6-8 dalgalanmalarla <strong>a\u015f\u0131r\u0131 volatilite<\/strong> g\u00f6sterdi. Bu, cesaret isteyen bir durum &#8211; bir g\u00fcn i\u00e7inde bir\u00e7ok mavi \u00e7ip hissenin y\u0131ll\u0131k hareketinden daha fazla hareket edebilen bir hisseyle kar\u015f\u0131 kar\u015f\u0131yay\u0131z.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 (Eyl\u00fcl Sonras\u0131)<\/strong>: \u0130ki olas\u0131 senaryo:<\/p>\n<ul>\n<li><em>Olumlu Sonu\u00e7lar<\/em>: 40-60 $ aral\u0131\u011f\u0131 (%70-150 y\u00fckseli\u015f)<\/li>\n<li><em>Olumsuz Sonu\u00e7lar<\/em>: 12-18 $ aral\u0131\u011f\u0131 (%20-50 d\u00fc\u015f\u00fc\u015f)<\/li>\n<\/ul>\n<p><strong>2026 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: Eyl\u00fcl sonu\u00e7lar\u0131 olumluysa, Faz 3 planlamas\u0131 h\u0131zlanarak 65-85 $ beklenir. Olumsuzsa, di\u011fer \u00fcr\u00fcn hatt\u0131 varl\u0131klar\u0131 etraf\u0131nda yeniden yap\u0131land\u0131rma 15-25 $ aral\u0131\u011f\u0131n\u0131 destekleyebilir.<\/p>\n<p><strong>2028 Projeksiyonu<\/strong>: Ba\u015far\u0131l\u0131 ticarile\u015fme DNTH&#8217;yi 120-180 $ seviyelerine ta\u015f\u0131yabilir, bu da n\u00f6rom\u00fcsk\u00fcler hastal\u0131k alan\u0131nda milyar dolarl\u0131k piyasa de\u011feri anlam\u0131na gelir.<\/p>\n<p><strong>2030 Vizyonu<\/strong>: Kompleman terap\u00f6tiklerinde pazar liderli\u011fi, kusursuz klinik program y\u00fcr\u00fctmesiyle 250 $+ de\u011ferlemeleri hakl\u0131 \u00e7\u0131karabilir.<\/p>\n<p><strong>Karar<\/strong>: <strong>Y\u00dcKSEK R\u0130SKL\u0130 ALIM<\/strong> &#8211; sadece spek\u00fclatif portf\u00f6y k\u0131sm\u0131 i\u00e7in uygundur. Eyl\u00fcl kataliz\u00f6r\u00fc bu yat\u0131r\u0131m\u0131 ikili bir bahise d\u00f6n\u00fc\u015ft\u00fcr\u00fcr &#8211; ya b\u00fcy\u00fck kazan\u00e7lar ya da ac\u0131 kay\u0131plar.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Gece Uykunuzu Ka\u00e7\u0131racak Riskler<\/h3>\n<ul>\n<li><strong>Klinik Ba\u015far\u0131s\u0131zl\u0131k Riski<\/strong>: \u0130la\u00e7lar\u0131n %90&#8217;\u0131 klinik denemelerde ba\u015far\u0131s\u0131z olur. DNTH103 de bunlara kat\u0131labilir.<\/li>\n<li><strong>Nakit T\u00fcketimi<\/strong>: 309 milyon $ nakit olmas\u0131na ra\u011fmen, \u00e7eyrek ba\u015f\u0131na 30+ milyon $ kaybediyorlar (<a href=\"https:\/\/stockanalysis.com\/stocks\/dnth\/company\/\">2025 2. \u00c7eyrek Sonu\u00e7lar\u0131<\/a>)<\/li>\n<li><strong>Rekabet<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketleri benzer kompleman inhibit\u00f6rleri geli\u015ftiriyor<\/li>\n<li><strong>Reg\u00fclasyon Engelleri<\/strong>: FDA onay\u0131 iyi verilse bile asla garanti de\u011fildir<\/li>\n<\/ul>\n<h3>Yat\u0131r\u0131mc\u0131lara Umut Veren Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Oybirli\u011fi Analist Deste\u011fi<\/strong>: T\u00fcm 12 analist AL \u00f6nerisi veriyor, ortalama hedef fiyat 52 $ (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/DNTH\/forecast\/\">MarketBeat Verileri<\/a>)<\/li>\n<li><strong>Pazar F\u0131rsat\u0131<\/strong>: Sadece ABD&#8217;de 100.000+ gMG hastas\u0131 daha iyi tedaviye ihtiya\u00e7 duyuyor<\/li>\n<li><strong>Mali Dayanak<\/strong>: Nakit 2027 sonuna kadar geli\u015ftirme i\u00e7in zaman sa\u011fl\u0131yor<\/li>\n<li><strong>Son Kurumsal Al\u0131mlar<\/strong>: <a href=\"https:\/\/dianthustx.com\">Candriam S.C.A.<\/a> ve di\u011fer fonlar pozisyon art\u0131r\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Ak\u0131ll\u0131ca Tahsis Edin<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5&#8217;inden fazlas\u0131n\u0131 tek bir biyotek hisseye koymay\u0131n<\/li>\n<li><strong>A\u00e7\u0131kl\u0131k Bekleyin<\/strong>: \u0130kili riski \u00f6nlemek i\u00e7in Eyl\u00fcl sonu\u00e7lar\u0131n\u0131 BEKLEMEY\u0130 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong>: Sonu\u00e7lar \u00f6ncesi al\u0131m yapacaksan\u0131z, al\u0131mlar\u0131 birka\u00e7 haftaya yay\u0131n\u0131z<\/li>\n<li><strong>Stop-Loss Koyun<\/strong>: Volatilite nedeniyle %15-20 stop-loss ile kendinizi koruyun<\/li>\n<\/ol>\n<p>Espiri: &#8220;DNTH ticareti, t\u0131bbi e\u011fitim olmadan beyin cerrahisi yapmak gibidir &#8211; heyecan verici ama hastay\u0131&#8230; ve g\u00f6mle\u011finizi kaybedebilece\u011finizi fark edene kadar!&#8221;<\/p>\n<h2>\u2705 Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ hisselerini sunan ve makul \u00fccretlere sahip oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap A\u00e7\u0131n ve Fon Yat\u0131r\u0131n<\/td>\n<td>Tamamen kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>DNTH&#8217;yi \u0130yice Ara\u015ft\u0131r\u0131n<\/td>\n<td>Kompleman inhibit\u00f6rl\u00fc\u011f\u00fc yakla\u015f\u0131m\u0131n\u0131n bilimini anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limit Emri Verin<\/td>\n<td>Volatil piyasalarda fazla \u00f6deme yapmamak i\u00e7in maksimum fiyat\u0131 yakla\u015f\u0131k 24 $ olarak belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Klinik Takvimi Takip Edin<\/td>\n<td>Eyl\u00fcl sonu\u00e7 tarihini izleyin ve volatiliteye haz\u0131rlan\u0131n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Biyotek Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun<\/h2>\n<p><a href=\"\/blog\">Pocket Option blog<\/a> stratejileriyle ilgilenenler i\u00e7in platform, biyotek ticareti i\u00e7in benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; K\u00fc\u00e7\u00fck pozisyonlarla denemek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong> &#8211; Tek belge KYC ile dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Karlar\u0131n\u0131za \u00e7e\u015fitli y\u00f6ntemlerle eri\u015fin<\/li>\n<li><strong>Ger\u00e7ek zamanl\u0131 uyar\u0131lar<\/strong> &#8211; Fiyat hareketleri ve haber olaylar\u0131ndan an\u0131nda haberdar olun<\/li>\n<\/ul>\n<p>D\u00fc\u015f\u00fck giri\u015f engeli, Pocket Option&#8217;u DNTH gibi y\u00fcksek volatiliteye sahip hisselerle denemek isteyen yeni ba\u015flayanlar i\u00e7in ideal k\u0131lar, b\u00fcy\u00fck sermaye taahh\u00fct etmeden.<\/p>\n<h2>\ud83c\udf0d Dianthus 2025&#8217;te: Otoimm\u00fcn Tedavide Devrim<\/h2>\n<p>Dianthus Therapeutics, otoimm\u00fcn hastal\u0131klara y\u00f6nelik \u00f6zel bir imm\u00fcnoloji alan\u0131 olan kompleman terap\u00f6tiklerinde \u00f6nc\u00fc konumdad\u0131r. \u00d6nc\u00fc ila\u00e7lar\u0131 claseprubart (DNTH103), miyastenia gravis gibi durumlar\u0131 tedavi etmek i\u00e7in klasik kompleman yolunu se\u00e7ici olarak inhibe eden yenilik\u00e7i bir yakla\u015f\u0131md\u0131r.<\/p>\n<p>\u015eirket, Faz 2 kayd\u0131n\u0131 planlanandan \u00f6nce tamamlad\u0131 ve 300 milyon dolar\u0131n \u00fczerinde nakit ile g\u00fc\u00e7l\u00fc finansal destek sa\u011fl\u0131yor. Onlar\u0131 \u00f6zellikle ilgin\u00e7 k\u0131lan, herkese her \u015feyi yapmaya \u00e7al\u0131\u015fmak yerine, en iyi s\u0131n\u0131f stat\u00fcs\u00fcne ula\u015fabileceklerine inand\u0131klar\u0131 kompleman inhibit\u00f6rl\u00fc\u011f\u00fcne odaklanmalar\u0131d\u0131r.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025&#8217;te Dianthus ara\u015ft\u0131rmac\u0131lar\u0131, ila\u00e7 adaylar\u0131n\u0131n 60 g\u00fcnl\u00fck yar\u0131 \u00f6mr\u00fcn\u00fcn (antikorlar i\u00e7in ola\u011fan\u00fcst\u00fc uzun) haftal\u0131k enjeksiyonlar yerine ayl\u0131k dozlamaya izin verebilece\u011fini ke\u015ffettiler &#8211; klinik denemeler ba\u015far\u0131l\u0131 olursa hasta ya\u015fam kalitesi i\u00e7in potansiyel bir oyun de\u011fi\u015ftirici.<\/p>\n"},"faq":[{"question":"Dianthus Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Dianthus Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"DNTH hisseleri ne kadar risklidir?","answer":"DNTH hisseleri y\u00fcksek volatiliteye sahip olup klinik deneme sonu\u00e7lar\u0131na ba\u011fl\u0131 olarak b\u00fcy\u00fck fiyat dalgalanmalar\u0131 ya\u015fayabilir. Bu nedenle sadece portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131 i\u00e7in uygun olan y\u00fcksek riskli bir yat\u0131r\u0131md\u0131r."},{"question":"Eyl\u00fcl 2025'te neden \u00f6nemli bir tarih var?","answer":"\u015eirket, Eyl\u00fcl 2025'te \u00f6nc\u00fc ila\u00e7 aday\u0131 DNTH103 i\u00e7in Faz 2 MaGic deneme sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Bu sonu\u00e7lar hissenin y\u00f6n\u00fcn\u00fc belirleyecek kritik bir kataliz\u00f6r olacakt\u0131r."},{"question":"Yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 DNTH gibi biyotek hisselerine yat\u0131rmamal\u0131, Eyl\u00fcl sonu\u00e7lar\u0131n\u0131 beklemeyi d\u00fc\u015f\u00fcnebilir, al\u0131mlar\u0131 dolar maliyet ortalamas\u0131 y\u00f6ntemiyle yaymal\u0131 ve volatiliteye kar\u015f\u0131 stop-loss kullanmal\u0131s\u0131n\u0131z."},{"question":"Pocket Option biyotek hisse ticareti i\u00e7in neden uygundur?","answer":"Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7oklu para \u00e7ekme se\u00e7enekleri ve ger\u00e7ek zamanl\u0131 uyar\u0131lar sunarak yeni ba\u015flayanlar\u0131n y\u00fcksek volatiliteye sahip biyotek hisseleriyle deney yapmas\u0131n\u0131 kolayla\u015ft\u0131r\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Dianthus Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Dianthus Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"DNTH hisseleri ne kadar risklidir?","answer":"DNTH hisseleri y\u00fcksek volatiliteye sahip olup klinik deneme sonu\u00e7lar\u0131na ba\u011fl\u0131 olarak b\u00fcy\u00fck fiyat dalgalanmalar\u0131 ya\u015fayabilir. Bu nedenle sadece portf\u00f6y\u00fcn\u00fcz\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131 i\u00e7in uygun olan y\u00fcksek riskli bir yat\u0131r\u0131md\u0131r."},{"question":"Eyl\u00fcl 2025'te neden \u00f6nemli bir tarih var?","answer":"\u015eirket, Eyl\u00fcl 2025'te \u00f6nc\u00fc ila\u00e7 aday\u0131 DNTH103 i\u00e7in Faz 2 MaGic deneme sonu\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak. Bu sonu\u00e7lar hissenin y\u00f6n\u00fcn\u00fc belirleyecek kritik bir kataliz\u00f6r olacakt\u0131r."},{"question":"Yat\u0131r\u0131m yaparken nelere dikkat etmeliyim?","answer":"Portf\u00f6y\u00fcn\u00fcz\u00fcn %2-5'inden fazlas\u0131n\u0131 DNTH gibi biyotek hisselerine yat\u0131rmamal\u0131, Eyl\u00fcl sonu\u00e7lar\u0131n\u0131 beklemeyi d\u00fc\u015f\u00fcnebilir, al\u0131mlar\u0131 dolar maliyet ortalamas\u0131 y\u00f6ntemiyle yaymal\u0131 ve volatiliteye kar\u015f\u0131 stop-loss kullanmal\u0131s\u0131n\u0131z."},{"question":"Pocket Option biyotek hisse ticareti i\u00e7in neden uygundur?","answer":"Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7oklu para \u00e7ekme se\u00e7enekleri ve ger\u00e7ek zamanl\u0131 uyar\u0131lar sunarak yeni ba\u015flayanlar\u0131n y\u00fcksek volatiliteye sahip biyotek hisseleriyle deney yapmas\u0131n\u0131 kolayla\u015ft\u0131r\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-30T17:05:42+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-30T17:05:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/\"},\"wordCount\":20,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/\",\"name\":\"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"datePublished\":\"2025-08-30T17:05:42+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-30T17:05:42+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131","datePublished":"2025-08-30T17:05:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/"},"wordCount":20,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/","name":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r - Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","datePublished":"2025-08-30T17:05:42+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Dianthus Therapeutics, Inc. (DNTH) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Dianthus Therapeutics, Inc. (DNTH) Hisse Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":361354,"slug":"how-to-buy-dianthus-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Dianthus Therapeutics, Inc. (DNTH) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Dianthus Therapeutics, Inc. (DNTH)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":361350,"slug":"how-to-buy-dianthus-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Dianthus Therapeutics, Inc. (DNTH) - Investimento em a\u00e7\u00f5es da Dianthus Therapeutics, Inc. (DNTH)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-dianthus-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/361355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=361355"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/361355\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334081"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=361355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=361355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=361355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}